BioCentury | Oct 9, 2014
Distillery Therapeutics
Indication: Cancer
...Target/marker/pathway Summary Licensing status Publication and contact information Cancer Brain cancer MicroRNA-33a (miR-33a); phosphodiesterase-8A (PDE-8A); UV radiation resistance associated (UVRAG)...
...In patient glioblastoma multiforme samples, high expression of miR-33a and low expression of PDE-8A and UVRAG...
...a miR-33a-targeting locked nucleic acid (LNA) led to decreased tumor growth and increased PDE-8A and UVRAG...
...In patient glioblastoma multiforme samples, high expression of miR-33a and low expression of PDE-8A and UVRAG...
...a miR-33a-targeting locked nucleic acid (LNA) led to decreased tumor growth and increased PDE-8A and UVRAG...
